Michael J. Caulfield

ExxonMobil (United States) — United States

Medicine · Health Sciences

37h-index6.6kcitations90works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(22), Immunotherapy and Immune Responses(20), T-cell and B-cell Immunology(16), HIV Research and Treatment(11), Herpesvirus Infections and Treatments(11)

Publications90 total

The Interplay between Process Conceptualization and Experimental Research─Accelerating and Guiding Catalysis to Process Breakthroughs
ACS Catalysis·2022· 8 cited
Catalytic limitations on alkane dehydrogenation under H<sub>2</sub>deficient conditions relevant to membrane reactors
Energy & Environmental Science·2022· 23 cited
Partial oxidation of alkanes by dioxiranes formed <i>in situ</i> at low temperature
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences·2017· 5 citedOpen Access
Supplementary material from "Partial oxidation of alkanes by dioxiranes formed <i>in situ</i> at low temperature"
Figshare·2017Open Access
Maine v. Mathematics: A Tale of Reapportionment, Calculation and Indignation
The Mathematical Intelligencer·2016
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Nature Structural & Molecular Biology·2013· 342 citedOpen Access
A case for research consortia to accelerate vaccine candidate discovery: identification of a stable antigenic HIV-1 Clade A Env candidate (P6370)
The Journal of Immunology·2013
Identification of an HIV-1 Clade A Envelope That Exhibits Broad Antigenicity and Neutralization Sensitivity and Elicits Antibodies Targeting Three Distinct Epitopes
Journal of Virology·2013· 64 citedOpen Access
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Proceedings of the National Academy of Sciences·2013· 241 citedOpen Access
Varicella Zoster Virus-Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications
Clinical Infectious Diseases·2013· 84 citedOpen Access
Rapid, Quantitative Mapping of Anti-HIV Type 1 Envelope Serum Antibody Specificities
AIDS Research and Human Retroviruses·2013· 1 citedOpen Access
Validation of Automated Dilution and Transfer Methods for Rapid Assessment of Functional Immune Responses to Meningococcal Vaccines
World Journal of Vaccines·2013Open Access
What If? How Apportionment Methods Choose Our Presidents
Mathematics Teacher Learning and Teaching PK-12·2012· 1 cited
Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
Retrovirology·2012· 1 citedOpen Access
Measuring hydrochloric acid and ammonium hydroxide permeation in bulk chemical distribution
2012
Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys
Vaccine·2011· 24 cited
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age
Vaccine·2011· 59 cited
Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
Vaccine·2011· 83 cited
Major depressive disorder and immunity to varicella-zoster virus in the elderly
Brain Behavior and Immunity·2011· 87 citedOpen Access
Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
Journal of Biological Chemistry·2010· 4 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jeffrey G. Smith(13), Tong‐Ming Fu(7), Myron J. Levin(7), John W. Shiver(6), Rocio D. Marchese(6), Ivan S. F. Chan(6), Robert K. Evans(5), James C. Cook(5), J. Clair(5), Robin M. Kaufhold(5), Timothy W. Tobery(5), Liming Guan(4), Joseph G. Joyce(4), Paul M. Keller(4), David B. Volkin(4), Emilio A. Emini(4), Michael N. Oxman(4), Gary R. Johnson(4), Anthony Hayward(4), Michael R. Irwin(4)